Advertisement
Clinical and Epidemiological Investigations

Clinical and Immunological Effects of Recombinant Interleukin 2 Given by Repetitive Weekly Cycles to Patients with Cancer

Paul M. Sondel, Peter C. Kohler, Jacquelyn A. Hank, Karen H. Moore, Nancy S. Rosenthal, Jeff A. Sosman, Robin Bechhofer and Barry Storer
DOI:  Published May 1988

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2001 to January 2021

AbstractFull-text HTMLPDF
Total6031524

Cited By

Article Information

Volume 48, Issue 9, pp. 2561-2567

PubMed 
3258545
Published By 
American Association for Cancer Research
Print ISSN 
0008-5472
Online ISSN 
1538-7445
History 
  • Received October 23, 1987
  • Revision received January 22, 1988
  • Accepted February 4, 1988
  • Published first May 1, 1988.
Copyright & Usage 
©1988 American Association for Cancer Research.

Author Information

  1. Paul M. Sondel2,
  2. Peter C. Kohler,
  3. Jacquelyn A. Hank,
  4. Karen H. Moore,
  5. Nancy S. Rosenthal,
  6. Jeff A. Sosman,
  7. Robin Bechhofer, and
  8. Barry Storer
  1. Departments of Pediatrics [P. M. S.], Human Oncology [P. M. S., P. C. K., J. A. H., K. H. M., N. S. R., J. A. S., B. S.], Genetics [P. M. S.], and Statistics [R. B., B. S.], University of Wisconsin, Madison, Wisconsin 53792
Back to top

Open full page PDF
Article Alerts
Email Article
Citation Tools
Clinical and Immunological Effects of Recombinant Interleukin 2 Given by Repetitive Weekly Cycles to Patients with Cancer
Paul M. Sondel, Peter C. Kohler, Jacquelyn A. Hank, Karen H. Moore, Nancy S. Rosenthal, Jeff A. Sosman, Robin Bechhofer and Barry Storer
Cancer Res May 1 1988 (48) (9) 2561-2567;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement